Financials
Financial year 2025
MF PHARMA from Liège, company number BE0790439043, closed financial year 2025 with a result of € 34,505 after tax. For that financial year MF PHARMA recorded a gross margin of € 55,691 and equity of € 15,747. Compared with financial year 2024, the result moved from € 39,953 to € 34,505. The company is profitable. The buffer shrank hard: equity is 78 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 14, 2026.
€ 15,747
▼ 78% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 34,505
▼ 14% vs 2024
Profit after tax over the fiscal year.
€ 74,094
▼ 7% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 90,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 2,137
▼ 78% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1,754
▼ 75% vs 2024
Loans from banks and other lenders, long and short.
€ 809
▲ 230% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 23,773
▲ 26% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 8,811 | € 39,410 | € 58,808 | € 55,691 | ▼ 5% |
| Profit after taxes | € 6,944 | € 23,979 | € 39,953 | € 34,505 | ▼ 14% |
| Equity | € 8,144 | € 31,290 | € 71,242 | € 15,747 | ▼ 78% |
| Total debts | € 7,172 | € 32,595 | € 25,923 | € 80,282 | ▲ 210% |
| Cash | € 7,330 | € 37,381 | € 79,493 | € 74,094 | ▼ 7% |
| Retained profit | € 6,144 | € 29,290 | € 69,242 | € 13,747 | ▼ 80% |
| Dividend | € 800 | € 833 | € 0 | € 90,000 | |
| Bank debt | € 0 | € 11,815 | € 6,882 | € 1,754 | ▼ 75% |
| Balance sheet total | € 15,316 | € 63,885 | € 97,165 | € 96,029 | ▼ 1% |
Key figures of MF PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MF PHARMA?
What happened at MF PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 34,505 (▼ 14% vs 2024). Source: NBB ↗
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 6,944 profit in 2022 to € 34,505 profit in 2025.
Paid € 29,129 in corporate taxes since 2022.
Best year ever: 2024, with € 39,953 profit.
Paid out € 91,633 in dividends to the owners in total.
A new publication or filing at MF PHARMA? We notify you, reason included.
Follow MF PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Margaux FISETTE
Administrator-manager
Establishments
Establishment units
Physical locations of this company
Quai de Rome 48 box 51
4000 Liège
Quai de Rome 48/51
4000 Liège
Active since 1 October 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0790.439.043
- VAT number
- BE 0790.439.043
- Registered office
- Quai de Rome 48 bus 51, 4000 Liège
- Names & denominations
- MF PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 September 2022
- Peppol
- Active · Active since 23 Oct 2025
- Contact
- [email protected]
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Vervaardiging van overige farmaceutische producten
Vervaardiging van geneesmiddelen
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels